NCT00790569 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Patients receive oral varenicline once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. varenicline: Given orally
- id
- FG000
- title
- Arm I
- description
- Patients receive oral varenicline placebo once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. placebo: Given orally
- id
- FG001
- title
- Arm II
- description
- Patients receive a nicotine patch, with doses tapering over time for a total of 26 weeks. Patients also receive nicotine gum to quell breakthrough urges. Patients may stop treatment when a comfortable level of smoking abstinence is reached. nicotine: Given transdermally and orally
- id
- FG002
- title
- Arm III
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 20
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 20
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 1
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Hospitalized
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Residential Treatment
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 3
- type
- Incarcerated
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 137
- group Id
- FG001
- num Subjects
- 45
- group Id
- FG002
- num Subjects
- 133
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 115
- group Id
- FG001
- num Subjects
- 35
- group Id
- FG002
- num Subjects
- 107
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 22
- group Id
- FG001
- num Subjects
- 10
- group Id
- FG002
- num Subjects
- 26
- type
- NOT COMPLETED
- title
- End of Treatment (6 Month Interview)
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 66
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 50
- type
- Lost to Follow-up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 137
- group Id
- FG001
- num Subjects
- 45
- group Id
- FG002
- num Subjects
- 133
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 71
- group Id
- FG001
- num Subjects
- 26
- group Id
- FG002
- num Subjects
- 83
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 66
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 50
- type
- NOT COMPLETED
- title
- End of Study (12 Month Interview)
Complete source fields
- groups
- description
- Patients receive oral varenicline once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. varenicline: Given orally
- id
- FG000
- title
- Arm I
- description
- Patients receive oral varenicline placebo once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. placebo: Given orally
- id
- FG001
- title
- Arm II
- description
- Patients receive a nicotine patch, with doses tapering over time for a total of 26 weeks. Patients also receive nicotine gum to quell breakthrough urges. Patients may stop treatment when a comfortable level of smoking abstinence is reached. nicotine: Given transdermally and orally
- id
- FG002
- title
- Arm III
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 20
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 20
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 1
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Hospitalized
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Residential Treatment
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 3
- type
- Incarcerated
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 137
- group Id
- FG001
- num Subjects
- 45
- group Id
- FG002
- num Subjects
- 133
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 115
- group Id
- FG001
- num Subjects
- 35
- group Id
- FG002
- num Subjects
- 107
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 22
- group Id
- FG001
- num Subjects
- 10
- group Id
- FG002
- num Subjects
- 26
- type
- NOT COMPLETED
- title
- End of Treatment (6 Month Interview)
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 66
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 50
- type
- Lost to Follow-up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 137
- group Id
- FG001
- num Subjects
- 45
- group Id
- FG002
- num Subjects
- 133
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 71
- group Id
- FG001
- num Subjects
- 26
- group Id
- FG002
- num Subjects
- 83
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 66
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 50
- type
- NOT COMPLETED
- title
- End of Study (12 Month Interview)
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle